(Q40632767)

22 September 2017

title

Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A (English)

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700629

12 March 2024

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502229

12 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700629

12 March 2024

author name string

Jun-ying Zheng

1

1 reference

22 September 2017

Danlin Chen

2

1 reference

22 September 2017

Justin Chan

3

1 reference

22 September 2017

Duan Yu

4

1 reference

22 September 2017

Eugene Ko

5

1 reference

22 September 2017

Shen Pang

6

1 reference

22 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14502229

12 March 2024

publication date

1 October 2003

1 reference

full work available at URL

22 September 2017

https://www.nature.com/articles/7700629.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502229

https://www.nature.com/articles/7700629

12 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700629

https://www.nature.com/articles/7700629.pdf

12 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700629

12 March 2024

1 reference

22 September 2017

volume

10

1 reference

22 September 2017

issue

10

1 reference

22 September 2017

page(s)

764-770

1 reference

Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Transcriptionally regulated adenoviruses for prostate-specific gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Superior tissue-specific expression from tyrosinase and prostate-specific antigen promoters/enhancers in helper-dependent compared with first-generation adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Ex vivo and in vitro studies of transgene expression in rat astrocytes transduced with lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Prostate-specific targeting using PSA promoter-based lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Progress in transcriptionally targeted and regulatable vectors for genetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

The promoter of the prostate-specific antigen gene contains a functional androgen responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Prostate-specific antigen expression is regulated by an upstream enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Lentiviral vectors: turning a deadly foe into a therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Production and concentration of pseudotyped HIV-1-based gene transfer vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Gene therapy: adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Adenovirus-mediated in vivo gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

Development of a self-inactivating lentivirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700629

inferred from DOI database lookup

7 January 2021

based on heuristic

2

57

495

S Pang

1997

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700629

12 March 2024

3

60

334

JP Latham

2000

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700629

12 March 2024

4

57

2559

R Rodriguez

1997

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700629

12 March 2024

26

62

2576

Y Li

2002

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7700629

12 March 2024

Identifiers

1 reference

Dimensions Publication ID

22 September 2017

1001178543

0 references

1 reference